703349008: Tafamidis meglumine (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Tafamidis meglumine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Halogen and/or halogen compound\Chlorine and/or chlorine compound\Chlorine compound\Organic chloride compound\Chlorinated hydrocarbon\Dichlorobenzene\Tafamidis meglumine (substance)
\Halogen and/or halogen compound\Halogenated hydrocarbon\Chlorinated hydrocarbon\Dichlorobenzene\Tafamidis meglumine (substance)

\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Tafamidis meglumine (substance)
\Organic compound\Organic chloride compound\Chlorinated hydrocarbon\Dichlorobenzene\Tafamidis meglumine (substance)
\Organic compound\Hydrocarbon\Halogenated hydrocarbon\Chlorinated hydrocarbon\Dichlorobenzene\Tafamidis meglumine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3008254018 Tafamidis meglumine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3008359014 Tafamidis meglumine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

843491000172114 tafamidis méglumine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tafamidis meglumine (substance)	Is a	Tafamidis	false	Inferred relationship	Some
Tafamidis meglumine (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Tafamidis	true	Inferred relationship	Some
Tafamidis meglumine (substance)	Is a	Central nervous system agent (substance)	true	Inferred relationship	Some
Tafamidis meglumine (substance)	Is a	Dichlorobenzene	true	Inferred relationship	Some
Tafamidis meglumine (substance)	Is a	Carboxylic acid	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tafamidis meglumine 20 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tafamidis meglumine (substance)	Inferred relationship	Some
Tafamidis meglumine 20 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Tafamidis meglumine (substance)	Inferred relationship	Some	1
Tafamidis meglumine 20 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Tafamidis meglumine (substance)	Inferred relationship	Some	1
Tafamidis meglumine 20 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Tafamidis meglumine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets